疫苗预防和控制流感：免疫实践咨询委员会（ACIP）的临时建议，2013 年。
Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013.
出版信息
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):356.
Abstract
This report summarizes recommendations approved on February 21, 2013, by the Advisory Committee on Immunization Practices (ACIP) for the use of influenza vaccines. An expanded 2013 ACIP influenza vaccination recommendation statement is scheduled to be published in MMWR Recommendations and Reports before the start of the 2013-14 influenza season. Providers should consult the expanded 2013 ACIP influenza vaccination statement for complete and updated information.
摘要
本报告总结了 2013 年 2 月 21 日免疫实践咨询委员会（ACIP）批准的流感疫苗使用建议。一份扩充的 2013 年 ACIP 流感疫苗接种建议声明计划在 2013-14 流感季开始前发布在《发病率和死亡率周报》的推荐与报告中。医务人员应查阅扩充的 2013 年 ACIP 流感疫苗接种声明以获取完整和最新的信息。
相似文献
1
Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013.疫苗预防和控制流感：免疫实践咨询委员会（ACIP）的临时建议，2013 年。
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):356.
2
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.疫苗预防和控制季节性流感：美国免疫实践咨询委员会在 2021-22 流感季的建议。
MMWR Recomm Rep. 2021 Aug 27;70(5):1-28. doi: 10.15585/mmwr.rr7005a1.
3
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.疫苗预防和控制季节性流感：免疫实践咨询委员会的建议-美国，2020-21 流感季。
MMWR Recomm Rep. 2020 Aug 21;69(8):1-24. doi: 10.15585/mmwr.rr6908a1.
4
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.疫苗预防和控制季节性流感：免疫实践咨询委员会的建议-美国，2018-19 流感季节。
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. doi: 10.15585/mmwr.rr6703a1.
5
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.《用疫苗预防和控制季节性流感：美国免疫实践咨询委员会的建议——2017 - 18流感季》
MMWR Recomm Rep. 2017 Aug 25;66(2):1-20. doi: 10.15585/mmwr.rr6602a1.
6
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.疫苗预防和控制季节性流感：免疫实践咨询委员会的建议-美国，2024-25 流感季节。
MMWR Recomm Rep. 2024 Aug 29;73(5):1-25. doi: 10.15585/mmwr.rr7305a1.
7
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.疫苗预防和控制季节性流感：免疫实践咨询委员会的建议-美国，2022-23 流感季节。
MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1.
8
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.季节性流感疫苗预防和控制：免疫实践咨询委员会的建议 - 美国，2019-20 流感季。
MMWR Recomm Rep. 2019 Aug 23;68(3):1-21. doi: 10.15585/mmwr.rr6803a1.
9
引用本文的文献
1
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016.2011-2016 年美国流感疫苗有效性网络中门诊患者的流感疫苗有效性按研究地点划分。
Influenza Other Respir Viruses. 2020 Jul;14(4):380-390. doi: 10.1111/irv.12741. Epub 2020 Apr 16.
2
Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.流感“训练”宿主增强对继发细菌性感染的易感性。
mBio. 2019 May 7;10(3):e00810-19. doi: 10.1128/mBio.00810-19.
3
Statement on Meningococcal Disease and the International Traveller.关于脑膜炎球菌病与国际旅行者的声明
Can Commun Dis Rep. 2015 May 7;41(5):100-107. doi: 10.14745/ccdr.v41i05a02.
4
Influenza vaccines: Evaluation of the safety profile.流感疫苗：安全性评估。
Hum Vaccin Immunother. 2018 Mar 4;14(3):657-670. doi: 10.1080/21645515.2017.1423153. Epub 2018 Jan 30.
5
Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older.65 岁及以上成年人接种四价流感疫苗的安全性和免疫原性。
Hum Vaccin Immunother. 2017 Sep 2;13(9):2058-2064. doi: 10.1080/21645515.2017.1344375.
6
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.2013 - 2014年美国6至35月龄儿童中一种四价流感灭活疫苗的免疫原性和安全性：一项II期随机试验的结果
J Pediatric Infect Dis Soc. 2016 Jun;5(2):170-9. doi: 10.1093/jpids/piv041. Epub 2015 Jul 16.
7
Practical review of immunizations in adult patients with cancer.成年癌症患者免疫接种的实践综述
Hum Vaccin Immunother. 2015;11(11):2606-14. doi: 10.1080/21645515.2015.1062189. Epub 2015 Jun 25.
8
Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.包含源自基因差异较大的甲型H1N1亚型流感病毒嵌合血凝素基因的重组甲型流感病毒的构建及免疫原性评估
PLoS One. 2015 Jun 10;10(6):e0127649. doi: 10.1371/journal.pone.0127649. eCollection 2015.
9
Updates in vaccination: recommendations for adult inflammatory bowel disease patients.疫苗接种更新：针对成年炎症性肠病患者的建议
World J Gastroenterol. 2015 Mar 21;21(11):3184-96. doi: 10.3748/wjg.v21.i11.3184.
10
Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.在年轻宿主中通过皮肤接种流感亚单位疫苗增强免疫反应。
Vaccine. 2015 Sep 8;33(37):4675-82. doi: 10.1016/j.vaccine.2015.01.086. Epub 2015 Mar 3.
Zotero 插件